- Report
- March 2024
- 193 Pages
Global
From €3243EUR$3,374USD£2,781GBP
€3603EUR$3,749USD£3,090GBP
- Report
- March 2024
- 182 Pages
Global
From €3243EUR$3,374USD£2,781GBP
€3603EUR$3,749USD£3,090GBP
- Report
- May 2024
- 194 Pages
Global
From €4758EUR$4,950USD£4,080GBP
- Report
- February 2024
- 175 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- January 2024
- 175 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- January 2024
- 200 Pages
Global
From €4806EUR$5,000USD£4,121GBP
- Report
- November 2023
- 148 Pages
Global
From €2402EUR$2,499USD£2,060GBP
- Report
- February 2024
- 137 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- January 2024
- 358 Pages
Global
€4801EUR$4,995USD£4,117GBP
- Report
- December 2023
- 290 Pages
Global
€4801EUR$4,995USD£4,117GBP
- Report
- February 2022
- 80 Pages
Global
From €5719EUR$5,950USD£4,904GBP
- Report
- August 2022
- 110 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- April 2023
- 112 Pages
Global
From €3797EUR$3,950USD£3,256GBP
- Report
- January 2022
- 60 Pages
Global
From €3797EUR$3,950USD£3,256GBP
- Report
- July 2022
- 146 Pages
Global
From €3061EUR$3,185USD£2,625GBP
€4373EUR$4,550USD£3,750GBP
- Report
- August 2022
- 118 Pages
Global
From €4565EUR$4,750USD£3,915GBP
- Report
- October 2022
- 120 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Report
- January 2022
- 120 Pages
Global
From €2403EUR$2,500USD£2,061GBP
- Report
- July 2018
- 50 Pages
Global
From €3840EUR$3,995USD£3,293GBP
- Report
- November 2022
- 565 Pages
Global
From €2403EUR$2,500USD£2,061GBP
Ischemic stroke is a type of stroke that occurs when a blood clot blocks an artery supplying blood to the brain. It is the most common type of stroke, accounting for approximately 87% of all stroke cases. Ischemic stroke is a major cause of death and disability worldwide, and is a major public health concern.
The ischemic stroke market within the context of cardiology is a rapidly growing market, driven by the increasing prevalence of stroke, the growing geriatric population, and the increasing demand for advanced treatments. The market is expected to be driven by the increasing adoption of minimally invasive treatments, such as thrombolysis and thrombectomy, as well as the development of novel treatments, such as stem cell therapy.
Some of the key players in the ischemic stroke market include Medtronic, Stryker, Johnson & Johnson, Boston Scientific, Abbott, and Terumo. Show Less Read more